Current Immunosuppressive Treatment for Takayasu Arteritis
Circ J. 2023 Dec 19. doi: 10.1253/circj.CJ-23-0780. Online ahead of print.ABSTRACTTakayasu arteritis (TAK) is a rare disease characterized by inflammation of large blood vessels, which results in vascular stenosis, occlusion, and aneurysm formation. The principal treatment has been glucocorticoids, but the recent emergence of biological disease-modifying anti-rheumatic drugs (bDMARDs), represented by tocilizumab (TCZ), has significantly changed the treatment landscape. Both cardiologists and cardiovascular surgeons will encounter patients receiving these drugs who require catheterization, other invasive procedures, or surg...
Source: Circulation Journal - December 20, 2023 Category: Cardiology Authors: Yoh Arita Tomohiko Ishibashi Yoshikazu Nakaoka Source Type: research
Prognostic Impact of Acute Myocardial Infarction-Related Ventricular Tachyarrhythmia in the Current Era
Circ J. 2023 Dec 19. doi: 10.1253/circj.CJ-23-0732. Online ahead of print.NO ABSTRACTPMID:38123295 | DOI:10.1253/circj.CJ-23-0732 (Source: Circulation Journal)
Source: Circulation Journal - December 20, 2023 Category: Cardiology Authors: Naoya Kataoka Teruhiko Imamura Source Type: research
Organ Damage and Quality of Life in Takayasu Arteritis - Evidence From a National Registry Analysis
CONCLUSIONS: Early diagnosis and effective treatment, particularly to prevent brain ischemia, visual impairment, and ischemic heart disease, may improve the quality of life of patients with Takayasu arteritis, especially women.PMID:38123296 | DOI:10.1253/circj.CJ-23-0656 (Source: Circulation Journal)
Source: Circulation Journal - December 20, 2023 Category: Cardiology Authors: Hajime Yoshifuji Yoshikazu Nakaoka Haruhito A Uchida Takahiko Sugihara Yoshiko Watanabe Sohei Funakoshi Mitsuaki Isobe Masayoshi Harigai Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis (JPVAS) Source Type: research
T1 Mapping Enabled Detection and Follow-up of Rare Immune Checkpoint Inhibitor Myocarditis
Circ J. 2023 Dec 20. doi: 10.1253/circj.CJ-23-0823. Online ahead of print.NO ABSTRACTPMID:38123297 | DOI:10.1253/circj.CJ-23-0823 (Source: Circulation Journal)
Source: Circulation Journal - December 20, 2023 Category: Cardiology Authors: Yusei Nishikawa Hiroyuki Takaoka Masato Kanda Sae Yumita Sadahisa Ogasawara Michiko Daimon Yoshitada Noguchi Shuhei Aoki Katsuya Suzuki Kazuki Yoshida Satomi Yashima Makiko Kinoshita Haruka Sasaki Noriko Suzuki-Eguchi Naoya Kato Yoshio Kobayashi Source Type: research
Prognostic Impact of Acute Myocardial Infarction-Related Ventricular Tachyarrhythmia in the Current Era - Reply
Circ J. 2023 Dec 19. doi: 10.1253/circj.CJ-23-0836. Online ahead of print.NO ABSTRACTPMID:38123293 | DOI:10.1253/circj.CJ-23-0836 (Source: Circulation Journal)
Source: Circulation Journal - December 20, 2023 Category: Cardiology Authors: Kenji Hanada Hirofumi Tomita Source Type: research
Current Immunosuppressive Treatment for Takayasu Arteritis
Circ J. 2023 Dec 19. doi: 10.1253/circj.CJ-23-0780. Online ahead of print.ABSTRACTTakayasu arteritis (TAK) is a rare disease characterized by inflammation of large blood vessels, which results in vascular stenosis, occlusion, and aneurysm formation. The principal treatment has been glucocorticoids, but the recent emergence of biological disease-modifying anti-rheumatic drugs (bDMARDs), represented by tocilizumab (TCZ), has significantly changed the treatment landscape. Both cardiologists and cardiovascular surgeons will encounter patients receiving these drugs who require catheterization, other invasive procedures, or surg...
Source: Circulation Journal - December 20, 2023 Category: Cardiology Authors: Yoh Arita Tomohiko Ishibashi Yoshikazu Nakaoka Source Type: research
Prognostic Impact of Acute Myocardial Infarction-Related Ventricular Tachyarrhythmia in the Current Era
Circ J. 2023 Dec 19. doi: 10.1253/circj.CJ-23-0732. Online ahead of print.NO ABSTRACTPMID:38123295 | DOI:10.1253/circj.CJ-23-0732 (Source: Circulation Journal)
Source: Circulation Journal - December 20, 2023 Category: Cardiology Authors: Naoya Kataoka Teruhiko Imamura Source Type: research
Organ Damage and Quality of Life in Takayasu Arteritis - Evidence From a National Registry Analysis
CONCLUSIONS: Early diagnosis and effective treatment, particularly to prevent brain ischemia, visual impairment, and ischemic heart disease, may improve the quality of life of patients with Takayasu arteritis, especially women.PMID:38123296 | DOI:10.1253/circj.CJ-23-0656 (Source: Circulation Journal)
Source: Circulation Journal - December 20, 2023 Category: Cardiology Authors: Hajime Yoshifuji Yoshikazu Nakaoka Haruhito A Uchida Takahiko Sugihara Yoshiko Watanabe Sohei Funakoshi Mitsuaki Isobe Masayoshi Harigai Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis (JPVAS) Source Type: research
T1 Mapping Enabled Detection and Follow-up of Rare Immune Checkpoint Inhibitor Myocarditis
Circ J. 2023 Dec 20. doi: 10.1253/circj.CJ-23-0823. Online ahead of print.NO ABSTRACTPMID:38123297 | DOI:10.1253/circj.CJ-23-0823 (Source: Circulation Journal)
Source: Circulation Journal - December 20, 2023 Category: Cardiology Authors: Yusei Nishikawa Hiroyuki Takaoka Masato Kanda Sae Yumita Sadahisa Ogasawara Michiko Daimon Yoshitada Noguchi Shuhei Aoki Katsuya Suzuki Kazuki Yoshida Satomi Yashima Makiko Kinoshita Haruka Sasaki Noriko Suzuki-Eguchi Naoya Kato Yoshio Kobayashi Source Type: research
Prognostic Impact of Acute Myocardial Infarction-Related Ventricular Tachyarrhythmia in the Current Era - Reply
Circ J. 2023 Dec 19. doi: 10.1253/circj.CJ-23-0836. Online ahead of print.NO ABSTRACTPMID:38123293 | DOI:10.1253/circj.CJ-23-0836 (Source: Circulation Journal)
Source: Circulation Journal - December 20, 2023 Category: Cardiology Authors: Kenji Hanada Hirofumi Tomita Source Type: research
Current Immunosuppressive Treatment for Takayasu Arteritis
Circ J. 2023 Dec 19. doi: 10.1253/circj.CJ-23-0780. Online ahead of print.ABSTRACTTakayasu arteritis (TAK) is a rare disease characterized by inflammation of large blood vessels, which results in vascular stenosis, occlusion, and aneurysm formation. The principal treatment has been glucocorticoids, but the recent emergence of biological disease-modifying anti-rheumatic drugs (bDMARDs), represented by tocilizumab (TCZ), has significantly changed the treatment landscape. Both cardiologists and cardiovascular surgeons will encounter patients receiving these drugs who require catheterization, other invasive procedures, or surg...
Source: Circulation Journal - December 20, 2023 Category: Cardiology Authors: Yoh Arita Tomohiko Ishibashi Yoshikazu Nakaoka Source Type: research
Prognostic Impact of Acute Myocardial Infarction-Related Ventricular Tachyarrhythmia in the Current Era
Circ J. 2023 Dec 19. doi: 10.1253/circj.CJ-23-0732. Online ahead of print.NO ABSTRACTPMID:38123295 | DOI:10.1253/circj.CJ-23-0732 (Source: Circulation Journal)
Source: Circulation Journal - December 20, 2023 Category: Cardiology Authors: Naoya Kataoka Teruhiko Imamura Source Type: research
Organ Damage and Quality of Life in Takayasu Arteritis - Evidence From a National Registry Analysis
CONCLUSIONS: Early diagnosis and effective treatment, particularly to prevent brain ischemia, visual impairment, and ischemic heart disease, may improve the quality of life of patients with Takayasu arteritis, especially women.PMID:38123296 | DOI:10.1253/circj.CJ-23-0656 (Source: Circulation Journal)
Source: Circulation Journal - December 20, 2023 Category: Cardiology Authors: Hajime Yoshifuji Yoshikazu Nakaoka Haruhito A Uchida Takahiko Sugihara Yoshiko Watanabe Sohei Funakoshi Mitsuaki Isobe Masayoshi Harigai Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis (JPVAS) Source Type: research
T1 Mapping Enabled Detection and Follow-up of Rare Immune Checkpoint Inhibitor Myocarditis
Circ J. 2023 Dec 20. doi: 10.1253/circj.CJ-23-0823. Online ahead of print.NO ABSTRACTPMID:38123297 | DOI:10.1253/circj.CJ-23-0823 (Source: Circulation Journal)
Source: Circulation Journal - December 20, 2023 Category: Cardiology Authors: Yusei Nishikawa Hiroyuki Takaoka Masato Kanda Sae Yumita Sadahisa Ogasawara Michiko Daimon Yoshitada Noguchi Shuhei Aoki Katsuya Suzuki Kazuki Yoshida Satomi Yashima Makiko Kinoshita Haruka Sasaki Noriko Suzuki-Eguchi Naoya Kato Yoshio Kobayashi Source Type: research
Predictive Value of CHADS < sub > 2 < /sub > , CHA < sub > 2 < /sub > DS < sub > 2 < /sub > -VASc and R < sub > 2 < /sub > -CHADS < sub > 2 < /sub > Scores for Short- and Long-Term Major Adverse Cardiac Events in Non-ST-Segment Elevation Myocardial Infarction
CONCLUSIONS: Patients with NSTEMI and higher CHADS2, CHA2DS2-VASc, and R2-CHADS2scores displayed a greater incidence of MACE.PMID:38104976 | DOI:10.1253/circj.CJ-23-0733 (Source: Circulation Journal)
Source: Circulation Journal - December 17, 2023 Category: Cardiology Authors: Takeo Horikoshi Takamitsu Nakamura Toru Yoshizaki Jun Nakamura Manabu Uematsu Tsuyoshi Kobayashi Yukio Saito Jun-Ei Obata Takao Sawanobori Hajime Takano Ken Umetani Tetsuya Asakawa Akira Sato Source Type: research
